Acumen Pharmaceuticals, Inc.
ABOS
Revenue
0.00
0.000.00%
-Assets
288.91M
▼-12.05M▼-4.01%
3 Months ChangeLiabilities
44.97M
▲6.03M▲15.50%
3 Months ChangeFree Cash Flow
-17.87M
▼-7.70M▼-75.63%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-13
Form 10-Q
ID: 0001576885-24-000092
2024-08-13
Form 8-K
ID: 0001576885-24-000090
2024-06-05
Form 8-K
ID: 0001576885-24-000067
2024-05-14
Form 10-Q
ID: 0001576885-24-000064
2024-05-14
Form 8-K
ID: 0001576885-24-000061
2024-03-26
Form 8-K
ID: 0001576885-24-000044
2024-03-19
Form 8-K
ID: 0001576885-24-000039
2024-02-01
Form 8-K
ID: 0001576885-24-000032
2024-01-12
Form 8-K
ID: 0001576885-24-000018
2024-01-08
Form 8-K
ID: 0001576885-24-000015